These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9700855

  • 1. Glycoprotein IIb/IIIa receptor antagonists inhibit the development of platelet procoagulant activity.
    Pedicord DL, Thomas BE, Mousa SA, Dicker IB.
    Thromb Res; 1998 Jun 15; 90(6):247-58. PubMed ID: 9700855
    [Abstract] [Full Text] [Related]

  • 2. Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728.
    Tsao PW, Forsythe MS, Mousa SA.
    Thromb Res; 1997 Oct 15; 88(2):137-46. PubMed ID: 9361367
    [Abstract] [Full Text] [Related]

  • 3. Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
    Lages B, Weiss HJ.
    Br J Haematol; 2001 Apr 15; 113(1):65-71. PubMed ID: 11328283
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
    Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS.
    J Clin Invest; 1996 Aug 01; 98(3):863-74. PubMed ID: 8698879
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of platelet-mediated clot retraction by integrin antagonists.
    Hantgan RR, Mousa SA.
    Thromb Res; 1998 Mar 15; 89(6):271-9. PubMed ID: 9669749
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
    Mousa SA, Khurana S, Forsythe MS.
    Arterioscler Thromb Vasc Biol; 2000 Apr 15; 20(4):1162-7. PubMed ID: 10764688
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF.
    J Am Coll Cardiol; 1995 Dec 15; 26(7):1665-71. PubMed ID: 7594101
    [Abstract] [Full Text] [Related]

  • 8. Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs.
    Mousa SA, Mu DX, Lucchesi BR.
    Stroke; 1997 Apr 15; 28(4):830-5; discussion 835-6. PubMed ID: 9099204
    [Abstract] [Full Text] [Related]

  • 9. In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time.
    Ammar T, Scudder LE, Coller BS.
    Circulation; 1997 Feb 04; 95(3):614-7. PubMed ID: 9024148
    [Abstract] [Full Text] [Related]

  • 10. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R, Fareed J.
    J Lab Clin Med; 2000 Mar 04; 135(3):247-55. PubMed ID: 10711863
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.
    Li Y, Spencer FA, Ball S, Becker RC.
    J Thromb Thrombolysis; 2000 Aug 04; 10(1):69-76. PubMed ID: 10947916
    [Abstract] [Full Text] [Related]

  • 12. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ.
    Thromb Haemost; 2000 Feb 04; 83(2):217-23. PubMed ID: 10739376
    [Abstract] [Full Text] [Related]

  • 13. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, McIntire LV.
    Circulation; 1995 Mar 01; 91(5):1354-62. PubMed ID: 7867173
    [Abstract] [Full Text] [Related]

  • 14. P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.
    Berny-Lang MA, Jakubowski JA, Sugidachi A, Barnard MR, Michelson AD, Frelinger AL.
    J Am Heart Assoc; 2013 May 15; 2(3):e000026. PubMed ID: 23676293
    [Abstract] [Full Text] [Related]

  • 15. The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies.
    Liem TK, Teel R, Shukla S, Silver D.
    J Vasc Surg; 1997 Jan 15; 25(1):124-30. PubMed ID: 9013915
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
    Matsumoto Y, Marukawa K, Okumura H, Adachi T, Tani T, Kimura Y.
    Thromb Res; 1999 Jul 01; 95(1):19-29. PubMed ID: 10403683
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Lorelli W, Thoolen MJ, Ramachandran N, Jackson S, De Grado W, Reilly TM.
    Cardiology; 1993 Jul 01; 83(5-6):374-82. PubMed ID: 7509257
    [Abstract] [Full Text] [Related]

  • 18. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
    Furman MI, Krueger LA, Frelinger AL, Barnard MR, Mascelli MA, Nakada MT, Michelson AD.
    Thromb Haemost; 2000 Sep 01; 84(3):492-8. PubMed ID: 11019977
    [Abstract] [Full Text] [Related]

  • 19. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L, Steiner B, Ulrichts H, Deckmyn H, Forestier M, Beer JH.
    Thromb Haemost; 2006 Dec 01; 96(6):774-80. PubMed ID: 17139372
    [Abstract] [Full Text] [Related]

  • 20. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.
    Konstantopoulos K, Kamat SG, Schafer AI, Bañez EI, Jordan R, Kleiman NS, Hellums JD.
    Circulation; 1995 Mar 01; 91(5):1427-31. PubMed ID: 7867183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.